| Identification | Back Directory | [Name]
2,7-Naphthalenedisulfonic acid, 5-[(2,3-dichlorobenzoyl)amino]-3-[2-[4-[2-[8-[(2,4-dichlorobenzoyl)amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]diazenyl]-2,5-dimethoxyphenyl]diazenyl]-4-hydroxy-, sodium salt (1:4) | [CAS]
170020-61-8 | [Synonyms]
FP21399
FP-21399
FP 21399
FP-21399 (Sodium)
2,7-Naphthalenedisulfonic acid, 5-[(2,3-dichlorobenzoyl)amino]-3-[2-[4-[2-[8-[(2,4-dichlorobenzoyl)amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]diazenyl]-2,5-dimethoxyphenyl]diazenyl]-4-hydroxy-, sodium salt (1:4) | [Molecular Formula]
C42H29Cl4N6NaO18S4 | [MOL File]
170020-61-8.mol | [Molecular Weight]
1198.75 |
| Hazard Information | Back Directory | [Uses]
FP-21399 is an active compound. | [References]
[1] A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: a phase I study |
|
|